Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
RLMD
$4.21
+1.20%
RLMD
· Relmada Therapeutics, Inc.
$4.21
+0.05 (+1.20%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$449.19M
Shares
106.69M
Volume · Nov 13
1.74M
Avg daily vol (3M)
1.35M
All webcasts
Earnings call · FY2026 Q2
Relmada Therapeutics, Inc. (RLMD) Q2 2026 Earnings Call
Diluted EPS
-$0.11
Net income
-$12.91M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document